Evidence map›Paper›PMID 20064214›Full record

ArticleBMC bioinformatics2010

Machine learning methods for metabolic pathway prediction.

Joseph M Dale, Liviu Popescu, Peter D Karp

Abstract read
In one paragraph

Article in BMC bioinformatics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Using supervised machine-learning approaches to understand abiotic stress tolerance and design resilient crops.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Machine learning for metabolic pathway optimization: A review.Computational and structural biotechnology journal · 2023
    Review
  9. Article
  10. Review
  11. Exploring synergies between plant metabolic modelling and machine learning.Computational and structural biotechnology journal · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Incorporating Machine Learning into Established Bioinformatics Frameworks.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Computational Methods for Predicting Functions at the mRNA Isoform Level.International journal of molecular sciences · 2020
    Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph M DaleBioinformatics Research Group, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA.
Liviu Popescu
Peter D Karp

Funding

Pathway Prediction and Assessment Integrating Multiple Evidence TypesR01LM009651 · NLM · SRI INTERNATIONAL · PI KARP, PETER D · 2007 to 2009
$525k
NLM NIH HHS LM009651NLM NIH HHS R01 LM009651
6 · The paper itself

Abstract

backgroundA key challenge in systems biology is the reconstruction of an organism's metabolic network from its genome sequence. One strategy for addressing this problem is to predict which metabolic pathways, from a reference database of known pathways, are present in the organism, based on the annotated genome of the organism.

resultsTo quantitatively validate methods for pathway prediction, we developed a large "gold standard" dataset of 5,610 pathway instances known to be present or absent in curated metabolic pathway databases for six organisms. We defined a collection of 123 pathway features, whose information content we evaluated with respect to the gold standard. Feature data were used as input to an extensive collection of machine learning (ML) methods, including naïve Bayes, decision trees, and logistic regression, together with feature selection and ensemble methods. We compared the ML methods to the previous PathoLogic algorithm for pathway prediction using the gold standard dataset. We found that ML-based prediction methods can match the performance of the PathoLogic algorithm. PathoLogic achieved an accuracy of 91% and an F-measure of 0.786. The ML-based prediction methods achieved accuracy as high as 91.2% and F-measure as high as 0.787. The ML-based methods output a probability for each predicted pathway, whereas PathoLogic does not, which provides more information to the user and facilitates filtering of predicted pathways.

conclusionsML methods for pathway prediction perform as well as existing methods, and have qualitative advantages in terms of extensibility, tunability, and explainability. More advanced prediction methods and/or more sophisticated input features may improve the performance of ML methods. However, pathway prediction performance appears to be limited largely by the ability to correctly match enzymes to the reactions they catalyze based on genome annotations.

Indexed as

Artificial IntelligenceMetabolic Networks and PathwaysComputational BiologyDatabases, FactualGenomeSoftware

Identifiers

PMID20064214
PMCPMC3146072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.